Company profile
ADIAL PHARMACEUTICALS, INC.
NASDAQ:ADILBiotechnology: Pharmaceutical Preparations
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04101227 | phase3 | completed | 2020-02-01 | 2022-02-18 | Adial Pharmaceuticals | Study to Evaluate AD04 in Adults With Alcohol Use Disorder (AUD) and Selected Serotonin Transporter Polymorphisms |
FDA applications (0)
No records yet.